Versor Investments LP lifted its holdings in shares of Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 251.6% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 41,085 shares of the company's stock after acquiring an additional 29,400 shares during the period. Versor Investments LP owned approximately 0.08% of Nu Skin Enterprises worth $298,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently modified their holdings of NUS. Prescott Group Capital Management L.L.C. grew its stake in Nu Skin Enterprises by 142.7% during the 1st quarter. Prescott Group Capital Management L.L.C. now owns 1,394,608 shares of the company's stock valued at $10,125,000 after acquiring an additional 819,972 shares in the last quarter. Pacer Advisors Inc. purchased a new position in Nu Skin Enterprises during the 1st quarter worth approximately $4,577,000. Susquehanna International Group LLP raised its stake in shares of Nu Skin Enterprises by 191.9% during the fourth quarter. Susquehanna International Group LLP now owns 702,127 shares of the company's stock worth $4,838,000 after purchasing an additional 461,608 shares during the last quarter. Two Sigma Advisers LP boosted its stake in shares of Nu Skin Enterprises by 61.2% in the fourth quarter. Two Sigma Advisers LP now owns 944,000 shares of the company's stock valued at $6,504,000 after buying an additional 358,400 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its stake in Nu Skin Enterprises by 47.1% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 1,052,384 shares of the company's stock valued at $7,640,000 after purchasing an additional 336,807 shares in the last quarter. Hedge funds and other institutional investors own 82.84% of the company's stock.
Insiders Place Their Bets
In other Nu Skin Enterprises news, Director Edwina D. Woodbury sold 4,532 shares of Nu Skin Enterprises stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $8.44, for a total transaction of $38,250.08. Following the completion of the transaction, the director owned 42,947 shares in the company, valued at approximately $362,472.68. The trade was a 9.55% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 2.00% of the company's stock.
Analysts Set New Price Targets
A number of equities analysts have weighed in on the stock. Zacks Research raised shares of Nu Skin Enterprises to a "hold" rating in a research note on Tuesday, August 12th. Wall Street Zen raised Nu Skin Enterprises from a "buy" rating to a "strong-buy" rating in a report on Friday, August 22nd. Three equities research analysts have rated the stock with a Hold rating, According to MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $6.88.
Check Out Our Latest Report on NUS
Nu Skin Enterprises Stock Down 2.3%
Shares of NUS traded down $0.28 on Wednesday, hitting $11.93. The company's stock had a trading volume of 84,030 shares, compared to its average volume of 654,506. The company has a quick ratio of 1.38, a current ratio of 2.01 and a debt-to-equity ratio of 0.27. Nu Skin Enterprises, Inc. has a fifty-two week low of $5.32 and a fifty-two week high of $12.40. The firm has a market capitalization of $590.51 million, a price-to-earnings ratio of 5.97 and a beta of 0.91. The firm's fifty day moving average price is $9.27 and its 200-day moving average price is $7.88.
Nu Skin Enterprises (NYSE:NUS - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The company reported $0.43 earnings per share for the quarter, topping analysts' consensus estimates of $0.25 by $0.18. Nu Skin Enterprises had a return on equity of 8.23% and a net margin of 6.20%.The firm had revenue of $386.14 million for the quarter, compared to the consensus estimate of $376.68 million. Nu Skin Enterprises has set its FY 2025 guidance at 1.150-1.350 EPS. On average, equities research analysts expect that Nu Skin Enterprises, Inc. will post 1.05 EPS for the current year.
Nu Skin Enterprises Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 10th. Shareholders of record on Friday, August 29th will be issued a $0.06 dividend. This represents a $0.24 dividend on an annualized basis and a yield of 2.0%. The ex-dividend date is Friday, August 29th. Nu Skin Enterprises's payout ratio is presently 11.94%.
Nu Skin Enterprises Company Profile
(
Free Report)
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Featured Articles

Before you consider Nu Skin Enterprises, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.
While Nu Skin Enterprises currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.